» Articles » PMID: 37528748

Why Adverse Outcome Pathways Need to Be FAIR

Abstract

Adverse outcome pathways (AOPs) provide evidence for demonstrating and assessing causality between measurable toxicological mechanisms and human or environmental adverse effects. AOPs have gained increasing attention over the past decade and are believed to provide the necessary steppingstone for more effective risk assessment of chemicals and materials and moving beyond the need for animal testing. However, as with all types of data and knowledge today, AOPs need to be reusable by machines, i.e., machine-actionable, in order to reach their full impact potential. Machine-actionability is supported by the FAIR principles, which guide findability, accessibility, interoperability, and reusability of data and knowledge. Here, we describe why AOPs need to be FAIR and touch on aspects such as the improved visibility and the increased trust that FAIRification of AOPs provides.

Citing Articles

Comprehensive mapping of the AOP-Wiki database: identifying biological and disease gaps.

Jaylet T, Coustillet T, Smith N, Viviani B, Lindeman B, Vergauwen L Front Toxicol. 2024; 6:1285768.

PMID: 38523647 PMC: 10958381. DOI: 10.3389/ftox.2024.1285768.

References
1.
Edwards S, Tan Y, Villeneuve D, Meek M, McQueen C . Adverse Outcome Pathways-Organizing Toxicological Information to Improve Decision Making. J Pharmacol Exp Ther. 2015; 356(1):170-81. DOI: 10.1124/jpet.115.228239. View

2.
Marx-Stoelting P, Riviere G, Luijten M, Aiello-Holden K, Bandow N, Baken K . A walk in the PARC: developing and implementing 21st century chemical risk assessment in Europe. Arch Toxicol. 2023; 97(3):893-908. PMC: 9968685. DOI: 10.1007/s00204-022-03435-7. View

3.
Nymark P, Rieswijk L, Ehrhart F, Jeliazkova N, Tsiliki G, Sarimveis H . A Data Fusion Pipeline for Generating and Enriching Adverse Outcome Pathway Descriptions. Toxicol Sci. 2017; 162(1):264-275. DOI: 10.1093/toxsci/kfx252. View

4.
Postigo R, Brosch S, Slattery J, van Haren A, Dogne J, Kurz X . EudraVigilance Medicines Safety Database: Publicly Accessible Data for Research and Public Health Protection. Drug Saf. 2018; 41(7):665-675. PMC: 5990579. DOI: 10.1007/s40264-018-0647-1. View

5.
Ankley G, Bennett R, Erickson R, Hoff D, Hornung M, Johnson R . Adverse outcome pathways: a conceptual framework to support ecotoxicology research and risk assessment. Environ Toxicol Chem. 2010; 29(3):730-41. DOI: 10.1002/etc.34. View